TD Cowen cuts STMicroelectronics to Hold
Hosted on MSN5h
TD Cowen Upgrades Linde (LIN)Fintel reports that on January 13, 2025, TD Cowen upgraded their outlook for Linde (NasdaqGS:LIN) from Hold to Buy. Analyst ...
TD Cowen analyst Daniel Brennan maintained a Hold rating on 10x Genomics (TXG – Research Report) today and set a price target of $18.00. The ...
On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...
Biden's rule to ban medical debt from credit reports is facing lawsuits from industry groups and criticism from GOP lawmakers ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.39% of ...
The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.
The S&P 500 gained 0.55% to close at 5,975.38. The Nasdaq Composite advanced 1.24% to end at 19,864.98. The Dow Jones ...
Applied Materials Inc (AMAT) stock saw a decline, ending the day at $171.65 which represents a decrease of $-5.34 or -3.02% from the prior close of $176.99. The stock opened at $174.72 and touched a ...
Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD Cowen report on the big investment themes of 2025, including shifting ...
El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...
TD Cowen raised the firm’s price target on Delta Air Lines (DAL) to $90 from $78 and keeps a Buy rating on the shares. The firm updated its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback